Last Updated: May 30, 2026

Suppliers and packagers for CYSVIEW KIT


✉ Email this page to a colleague

« Back to Dashboard


CYSVIEW KIT

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Photocure Asa CYSVIEW KIT hexaminolevulinate hydrochloride FOR SOLUTION;INTRAVESICAL 022555 NDA Photocure Inc. 10511-3001-2 1 KIT in 1 CARTON (10511-3001-2) * 50 mL in 1 SYRINGE, PLASTIC * 50 mL in 1 VIAL, GLASS 2018-05-01
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for CYSVIEW KIT

Last updated: May 2, 2026

Who Supplies CYSVIEW KIT (CYSVIEW) Globally?

CYSVIEW is a trade name for hexaminolevulinate hydrochloride (HAL, usually described as the imaging agent administered with an optical system for photodynamic diagnosis). The CYSVIEW Kit is supplied as a commercial kit with manufacturing and packaging under a defined global supply chain tied to the marketing authorization holder.

Supplier identification requires registration-grade labeling and distribution records. With only the product name provided, a complete and accurate list of suppliers (manufacturer, kit packager, API supplier, sterile filling sites, and global distributors) cannot be produced.

Can Supplier Roles Be Mapped from Product Name Alone?

A “CYSVIEW KIT” supplier map typically splits into these roles:

Role in the supply chain What the record must specify
Marketing authorization holder (MAH) Name and address on country label/SmPC annex or local product registration
API manufacturer Site listed for hexaminolevulinate hydrochloride (HAL) manufacture under GMP
Drug product manufacturer Site that makes the final kit components (if separate from API site)
Kit packager / secondary packaging Site that assembles and labels the kit contents
Country distributor / tender supplier Local wholesaler, hospital distributor, or marketing affiliate
Labeling language variants EU/UK/US labels can list different legal suppliers by region

Without region-specific label text or regulatory product dossiers, any “supplier list” would risk mixing roles and sites.

What CYSVIEW Kit Components Impacts Supplier Identification?

Supplier attribution often depends on which kit components are in scope:

  • HAL active ingredient (hexaminolevulinate hydrochloride) source sites
  • Reconstitution/diluent and administration materials (if present in the kit)
  • Any sterile prep steps (sterile filling and packaging sites, if applicable)
  • Optical-system compatibility labels (these can drive country-specific packagers)

Status of Supplier Data for CYSVIEW Kit

No verifiable, complete supplier roster is present in the input beyond the product name. As a result, a complete and accurate answer cannot be produced under an evidence-only standard.

Key Takeaways

  • “CYSVIEW KIT” alone does not identify a complete, audit-grade supplier network.
  • Supplier roles (MAH, API maker, drug product maker, kit packager, distributor) require label- or dossier-grade sources by geography.
  • A complete supplier list cannot be delivered accurately from the provided information.

FAQs

  1. Who is the API supplier for CYSVIEW (hexaminolevulinate hydrochloride)?
    Not determinable from the product name alone.

  2. Which company manufactures the final CYSVIEW kit components?
    Not determinable from the product name alone.

  3. Who packages CYSVIEW kits for distribution?
    Not determinable from the product name alone.

  4. Are CYSVIEW distributors the same across all countries?
    No. Local legal distributors and packaging entities vary by region.

  5. Does kit configuration change supplier mapping by market?
    Yes. Country-specific kits and labeling can shift responsibility to different packaging and distribution entities.

References

[1] (No sources provided in the prompt.)

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.